A genome-wide analysis of mRNA splicing changes in NSCLC compared to matched non-malignant lung tissues revealed that a large fraction of the identified differential splicing events were targets for QKI, suggesting that QKI is a major regulator of AS in lung cancer [223]. The gene discussed is QKI; the disease is lung carcinoma.